Zobrazeno 1 - 10
of 276
pro vyhledávání: '"Max Schlaak"'
Autor:
Lukas Heinlein, Roman C. Maron, Achim Hekler, Sarah Haggenmüller, Christoph Wies, Jochen S. Utikal, Friedegund Meier, Sarah Hobelsberger, Frank F. Gellrich, Mildred Sergon, Axel Hauschild, Lars E. French, Lucie Heinzerling, Justin G. Schlager, Kamran Ghoreschi, Max Schlaak, Franz J. Hilke, Gabriela Poch, Sören Korsing, Carola Berking, Markus V. Heppt, Michael Erdmann, Sebastian Haferkamp, Konstantin Drexler, Dirk Schadendorf, Wiebke Sondermann, Matthias Goebeler, Bastian Schilling, Eva Krieghoff-Henning, Titus J. Brinker
Publikováno v:
Communications Medicine, Vol 4, Iss 1, Pp 1-9 (2024)
Abstract Background Early detection of melanoma, a potentially lethal type of skin cancer with high prevalence worldwide, improves patient prognosis. In retrospective studies, artificial intelligence (AI) has proven to be helpful for enhancing melano
Externí odkaz:
https://doaj.org/article/b94e12d429514a5caf386ed1f4f44417
Autor:
Anastasia Tsakmaklis, Fedja Farowski, Rafael Zenner, Till Robin Lesker, Till Strowig, Hans Schlößer, Jonas Lehmann, Michael von Bergwelt-Baildon, Cornelia Mauch, Max Schlaak, Jana Knuever, Viola Schweinsberg, Lucie M. Heinzerling, Maria J. G. T. Vehreschild
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Composition of the intestinal microbiota has been correlated to therapeutic efficacy of immune checkpoint inhibitors (ICI) in various cancer entities including melanoma. Prediction of the outcome of such therapy, however, is still
Externí odkaz:
https://doaj.org/article/69ad8fc3b2f647bf81cbb0789a13962b
Autor:
Sebastian Mönch, Maurice M. Heimer, Michael Winkelmann, Anne Guertler, Max Schlaak, Amanda Tufman, Najib Ben Khaled, Enrico de Toni, Christoph B. Westphalen, Michael von Bergwelt-Baildon, Julien Dinkel, Philipp M. Kazmierczak, Michael Ingrisch, Nabeel Mansour, Marcus Unterrainer, Lucie Heinzerling, Jens Ricke, Wolfgang G. Kunz
Publikováno v:
Cancer Imaging, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Pseudoprogression (PsPD) is a rare response pattern to immune checkpoint inhibitor (ICI) therapy in oncology. This study aims to reveal imaging features of PsPD, and their association to other relevant findings. Methods Patients w
Externí odkaz:
https://doaj.org/article/2c2fcfaf0c564e3e9f88c328dca83c52
Autor:
Raphael Bodensohn, Simone Werner, Jonas Reis, Montserrat Pazos Escudero, Anna-Lena Kaempfel, Indrawati Hadi, Robert Forbrig, Farkhad Manapov, Stefanie Corradini, Claus Belka, Sebastian Theurich, Lucie Heinzerling, Max Schlaak, Maximilian Niyazi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 39, Iss , Pp 100573- (2023)
Purpose and objective: Adding stereotactic radiosurgery (SRS) to combined immune checkpoint therapy with ipilimumab and nivolumab (IPI + NIVO) has led to promising results for patients with melanoma brain metastases (MBM). This study retrospectively
Externí odkaz:
https://doaj.org/article/9b1e79de8947433b900371345deb39fb
Autor:
Leonie Müller-Jensen, Sarah Zierold, Judith M Versluis, Wolfgang Boehmerle, Petra Huehnchen, Matthias Endres, Raphael Mohr, Annette Compter, Christian U Blank, Tim Hagenacker, Friedegund Meier, Lydia Reinhardt, Anja Gesierich, Martin Salzmann, Jessica C Hassel, Selma Ugurel, Lisa Zimmer, Patricia Banks, Lavinia Spain, Jennifer A Soon, Tomohiro Enokida, Makoto Tahara, Katharina C Kähler, Ruth Seggewiss-Bernhardt, Catriona Harvey, Georgina V Long, Florian Schöberl, Louisa von Baumgarten, Thomas Hundsberger, Max Schlaak, Lars E French, Samuel Knauss, Lucie M Heinzerling
Publikováno v:
Data in Brief, Vol 45, Iss , Pp 108649- (2022)
Over the past decade, cancer immunotherapy with immune checkpoint inhibitors (ICIs) has significantly improved the outcome of many malignancies. However, with the broad use of ICIs, neurological immune related adverse events (irAE) are increasingly r
Externí odkaz:
https://doaj.org/article/c91a9542a832459593f5a6f29e793e54
Autor:
Markus V. Heppt, Teresa Amaral, Katharina C. Kähler, Lucie Heinzerling, Jessica C. Hassel, Markus Meissner, Nicole Kreuzberg, Carmen Loquai, Lydia Reinhardt, Jochen Utikal, Evelyn Dabrowski, Anja Gesierich, Claudia Pföhler, Patrick Terheyden, Kai-Martin Thoms, Lisa Zimmer, Thomas K. Eigentler, Michael C. Kirchberger, Henner M. Stege, Friedegund Meier, Max Schlaak, Carola Berking
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-9 (2019)
Abstract Background Uveal melanoma (UM) is highly refractory to treatment with dismal prognosis in advanced stages. The value of the combined checkpoint blockade with CTLA-4 and PD-1 inhibition in metastatic UM is currently unclear. Methods Patients
Externí odkaz:
https://doaj.org/article/39e18ef3acc940829b41d0958141f699
Autor:
Anne-Charlotte Niesert, Anne Guertler, Olga Schutti, Laura Engels, Michael Flaig, Lars E. French, Max Schlaak, Markus Reinholz
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 6, p adv00472 (2021)
Externí odkaz:
https://doaj.org/article/9d37ea8d536e4c9a9f2e930a91d28877
Autor:
Dirk Tomsitz, Max Schlaak, Sarah Zierold, Giulia Pesch, Thomas U. Schulz, Genoveva Müller, Christine Zecha, Lars E. French, Lucie Heinzerling
Publikováno v:
Cancers, Vol 14, Iss 13, p 3282 (2022)
Predictive markers for immune checkpoint inhibitor (ICI) therapy are needed. Thus, baseline blood counts have been investigated as biomarkers, showing that lymphopenia at the start of therapy with (ICI) is associated with a worse outcome in metastati
Externí odkaz:
https://doaj.org/article/1fbccf2f58c34945bcfcafb4b07edf8a
Autor:
Kinan Hayani, Kathrin Giehl, Jörg Kumbrink, Judith Fischer, Max Schlaak, Lars E. French, Andreas Wollenberg
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 15, p adv00241 (2020)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/1df769d34a4b40e585c90a83a404c4ea
Autor:
Lucie Heinzerling, Elisabeth Livingstone, Eleftheria Chorti, Selma Ugurel, Anja Gesierich, Jürgen C Becker, Peter Mohr, Max Schlaak, Rudolf Herbst, Sarah Knispel, Hildegard Lax, Carsten Weishaupt, Claudia Pföhler, Katharina C Kaehler, Jochen Utikal, Martin Kaatz, Jens Ulrich, Edgar Dippel, Michael Weichenthal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Immune checkpoint inhibition (ICI) is an essential treatment option in melanoma. Its outcome may be improved by a preceding radiation of metastases. This study aimed to investigate the impact of a preceding radiotherapy on the clinical out
Externí odkaz:
https://doaj.org/article/88535c53b95b4637b1aed1641c90cbb3